GHTC signed a Defense Health Research Consortium (DHRC) letter to Congress urging enactment of the fiscal year 2022 (FY22) Defense Appropriations Act to ensure that the Defense Health Research Programs, including the Congressionally Directed Medical Research Programs, are fully funded in FY22.
PDF
GHTC endorsed two letters from the Global Health Council's Tuberculosis (TB) Roundtable to the White House Office of Management and Budget urging support for domestic and global TB programs in the fiscal year 2023 budget.
Learn more
GHTC Multilateral Policy and Advocacy Officer Philip Kenol was selected as a finalist for Washington Global Health Alliance's (WGHA) Rising Star Award, which recognizes an individual age 40 or under who is making an exceptional impact in a global health organization or initiative.
Learn more
GHTC Director Jamie Bay Nishi was interviewed as part of a Mediaplanet campaign on neglected tropical diseases (NTDs) that was featured in the Guardian.
View
GHTC signed a letter urging the Senate to include at least $16 billion for pandemic preparedness in its version of the Build Back Better Act in order to deliver tangible national tools and capabilities that save lives, jobs, and money during future dangerous outbreaks.
PDF
GHTC’s director Jamie Bay Nishi was invited by the White House to deliver video remarks for the Global COVID-19 Summit held on September 22, 2021.
Learn more
GHTC sent a letter to the White House Office of Management and Budget (OMB), calling for the administration to sustain and protect global health R&D in the fiscal year 2022 (FY22) budget.
PDF
GHTC applauds the US government’s efforts to host a Global COVID-19 Summit on the margins of the United Nations General Assembly next week and calls on heads of state, multilateral and regional bodies, and private-sector and non-governmental leaders to take this moment to take a fresh look at how to tackle the pandemic globally and solve the inequities that have plagued the COVID-19 response the past year and a half.
Learn more